Regulators in Oregon are investigating a pending deal that would see UnitedHealth Group’s Optum subsidiary acquire home health provider Amedisys for an estimated $3.7 billion, with the regulators saying in a Securities and Exchange Commission filing that the deal is subject to “approval from the Oregon Health Authority (OHA) in connection with the Health Care Market Over
Regulators reviewing UnitedHealth’s $3.7B Amedisys acquisition
